Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Balius TE"'
Autor:
Finci LI; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Chakrabarti M; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Gulten G; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Finney J; National Cryo-EM Facility, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Grose C; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Fox T; National Cryo-EM Facility, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Yang R; Center for Molecular Microscopy, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Nissley DV; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., McCormick F; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Esposito D; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Balius TE; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Simanshu DK; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. dhirendra.simanshu@nih.gov.
Publikováno v:
Communications biology [Commun Biol] 2024 Mar 02; Vol. 7 (1), pp. 260. Date of Electronic Publication: 2024 Mar 02.
Autor:
Balius TE; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Tan YS; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Chakrabarti M; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.
Publikováno v:
Journal of computational chemistry [J Comput Chem] 2024 Jan 05; Vol. 45 (1), pp. 47-63. Date of Electronic Publication: 2023 Sep 25.
Autor:
Chakrabarti M; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Tan YS; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Balius TE; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. trent.balius@nih.gov.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2797, pp. 67-90.
Autor:
Bender BJ; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Gahbauer S; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Luttens A; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden., Lyu J; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Webb CM; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Stein RM; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Fink EA; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Balius TE; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, MD, USA., Carlsson J; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden., Irwin JJ; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Shoichet BK; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA. bshoichet@gmail.com.
Publikováno v:
Nature protocols [Nat Protoc] 2022 Jan; Vol. 17 (1), pp. 177.
Autor:
Bender BJ; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Gahbauer S; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Luttens A; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden., Lyu J; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Webb CM; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Stein RM; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Fink EA; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Balius TE; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, MD, USA., Carlsson J; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden., Irwin JJ; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA., Shoichet BK; Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, CA, USA. bshoichet@gmail.com.
Publikováno v:
Nature protocols [Nat Protoc] 2021 Oct; Vol. 16 (10), pp. 4799-4832. Date of Electronic Publication: 2021 Sep 24.
Autor:
Kamenik AS; Institute of General, Inorganic, and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck, University of Innsbruck, 6020 Innsbruck, Austria.; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158., Singh I; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158., Lak P; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158., Balius TE; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158 bshoichet@gmail.com Klaus.Liedl@uibk.ac.at trent.balius@nih.gov., Liedl KR; Institute of General, Inorganic, and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck, University of Innsbruck, 6020 Innsbruck, Austria; bshoichet@gmail.com Klaus.Liedl@uibk.ac.at trent.balius@nih.gov., Shoichet BK; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158 bshoichet@gmail.com Klaus.Liedl@uibk.ac.at trent.balius@nih.gov.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Sep 07; Vol. 118 (36).
Autor:
Van QN; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, National Cancer Institute RAS Initiative, Inc., Frederick, MD 21702, USA., Prakash P; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, National Cancer Institute RAS Initiative, Inc., Frederick, MD 21702, USA., Shrestha R; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, National Cancer Institute RAS Initiative, Inc., Frederick, MD 21702, USA., Balius TE; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, National Cancer Institute RAS Initiative, Inc., Frederick, MD 21702, USA., Turbyville TJ; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, National Cancer Institute RAS Initiative, Inc., Frederick, MD 21702, USA., Stephen AG; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, National Cancer Institute RAS Initiative, Inc., Frederick, MD 21702, USA.
Publikováno v:
Biomolecules [Biomolecules] 2021 Mar 03; Vol. 11 (3). Date of Electronic Publication: 2021 Mar 03.
Autor:
Stein RM; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States., Yang Y; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States., Balius TE; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., P.O. Box B, Frederick, Maryland 21702, United States., O'Meara MJ; Department of Computational Medicine and Bioinformatics, University of Michigan, Palmer Commons, 100 Washtenaw Ave. #2017, Ann Arbor, Michigan 48109, United States., Lyu J; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States., Young J; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States., Tang K; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States., Shoichet BK; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States., Irwin JJ; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.
Publikováno v:
Journal of chemical information and modeling [J Chem Inf Model] 2021 Feb 22; Vol. 61 (2), pp. 699-714. Date of Electronic Publication: 2021 Jan 25.
Publikováno v:
Journal of the American Chemical Society [J Am Chem Soc] 2020 Mar 18; Vol. 142 (11), pp. 4960-4964. Date of Electronic Publication: 2020 Mar 04.
Autor:
Tran TH; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702., Alexander P; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702., Dharmaiah S; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702., Agamasu C; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702., Nissley DV; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702., McCormick F; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702.; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA 94158., Esposito D; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702., Simanshu DK; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702., Stephen AG; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702., Balius TE; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702; trent.balius@nih.gov.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Feb 18; Vol. 117 (7), pp. 3363-3364. Date of Electronic Publication: 2020 Feb 11.